Companies / Kenai Therapeutics
Kenai Therapeutics
United States
Kenai Therapeutics is a clinical-stage biotechnology company that advances cell therapies and gene-modified medicines for the treatment of neurological conditions.
Kenai Therapeutics, based in United States, has 2 investors on file, among them Saisei Ventures and The Column Group. Its site was last checked 12 Nov 2026: site answers.
Investors
2 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
More from Saisei Ventures
5 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (100%).
See Saisei Ventures' full profile · Who invests alongside it
More from The Column Group
37 companies on its checked portfolioIts portfolio leans to Healthcare & Biotech (95%), Fintech (3%), E-commerce & Marketplaces (3%).
See The Column Group's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Kenai Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Saisei Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/kenaitx.com/investors
# also
GET /v1/companies/kenaitx.com
GET /v1/companies/kenaitx.com/news